Benjamin Looker
CIK 1859509 · Chief Legal Officer · last filed 2026-03-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.14M
Companies
2
Total Filings
17
Lifetime Open-Market Net
-$120.0K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ESPR | Chief Legal Officer | 679,348 | $3.15 | $2.14M | -$120.0K | 15 | 2026-03-18 |
| Trillium Therapeutics Inc. (TRIL) Delisted | General Counsel | — | $19.86 | — | $0 | 1 | 2021-05-05 |
Recent Filings · Page 2 of 2
17 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-04-20 | ESPR | Sell (S) | −1,290 | -$1.6K | EDGAR |
| 2023-03-15 | ESPR | Grant (A) | +20,500 | $0 | EDGAR |
| 2023-01-19 | ESPR | Sell (S) | −6,347 | -$44.4K | EDGAR |
| 2022-06-09 | ESPR | Grant (A) | — | $0 | EDGAR |
| 2022-01-28 | ESPR | Grant (A) | +70,800 | $0 | EDGAR |
| 2021-11-19 | — | Disp (D) | — | $0 | |
| 2021-05-05 | Trillium Therapeutics Inc. (TRIL) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 11–17 of 17
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.